Skip to main content
OpenTrials

Clinical trial condition

Disease, Hodgkin

Explore clinical trials studying Disease, Hodgkin. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Disease, Hodgkin trial results

Completed

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

NCT01100502

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 87 locations
View Trial Details
Completed

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma

NCT00848926

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 27 locations
View Trial Details
Completed

A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study

NCT00947856

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 17 locations
View Trial Details
Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

NCT01026415

Conditions
Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
  • Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

NCT00430846

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University St Louis, Missouri, United States
  • Weill Cornell Medical College New York, United States
  • University of Texas/MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

NCT01060904

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • UNC Lineberger Comprehensive Cancer Center / University of North Carolina Chapel Hill, North Carolina, United States
  • MD Anderson Cancer Center / University of Texas Houston, Texas, United States
  • British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

NCT01026233

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
View Trial Details

Related conditions